64. 血栓性血小板減少性紫斑病 Thrombotic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 92 / 薬物数 : 85 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 76

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05135442 (ClinicalTrials.gov)	December 1, 2021	6/11/2021	Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP	The Efficacy and Safety of Bortezomib as First-line Treatment for Acquired Thrombotic Thrombocytopen ...	Thrombotic Thrombocytopenic Purpura, Acquired	Drug: Bortezomib Injection	Peking Union Medical College Hospital	NULL	Not yet recruiting	18 Years	80 Years	All	30	Phase 4	China

First Previous1Next Last